Aims of the Committee
Review proposals submitted to the IAC for organizing future congresses (ICCs)
Responsibilities:
- Solicit proposals from national societies and submit recommendations to the board.
- Organize the presentation (in-person if feasible) with representatives of the top three proposals at the board meeting.
Chair
Dr. Fernando Schmitt, MD, FIAC (Portugal)
Professor Fernando Schmitt is a Professor of Pathology at the Medical Faculty of University of Porto, Senior Researcher and Head of Molecular Pathology Unit at IPATIMUP, Director of RISE (Clinical and Translational Research Network of the Medical Faculty), Past-President of the International Society of Breast Pathology and President of the International Academy of Cytology (IAC).
Members
dr. Syed Z. Ali, MD, FRCPath, FIAC (USA)
Prof. Ali serves as Professor of Pathology and Radiology at the Johns Hopkins University School of Medicine as well as the Director of the Division of Cytopathology at The Johns Hopkins Hospital. He received his Pathology residency training at North Shore University Hospital/Cornell University in New York with fellowships in Oncologic Surgical Pathology at Memorial Sloan-Kettering Cancer Center in New York and Cytopathology at The Johns Hopkins Hospital in Baltimore.
Known globally as an innovative educator, Prof. Ali has well over 375 invited lectures, keynote speeches and visiting professorships all over the world. In collaboration with international societies and universities, he directs or co-directs several annual major cytopathology tutorials.
Prof. Ali has published extensively with over 335 peer-reviewed articles in major scientific journals, over 35 books, book chapters and electronic media. Known for his expertise in “Thyroid” and “Pancreatic” cytopathology, his monograph on “The Bethesda System for Reporting Thyroid Cytopathology” (now in its 3rd edition) has been translated in 8 languages and is extensively used in medical practice all over the world. He is the founding editor-in-chief of the Journal of the American Society of Cytopathology (JASC) and a past-President of the American Society of Cytopathology (ASC). Presently, he serves as the President of the International Academy of Cytology (IAC) and Chair of the International Board of Cytopathology of the IAC. He is a fellow of both the Royal College of Pathologists (UK) and the IAC. He is recipient of the ASC’s “Warren R. Lang Award” in 1996, “President’s Award” in 2012, “Excellence in Education Award” in 2015, the IAC’s “Maurice Goldblatt Award” in 2019, Papanicolaou Society of Cytopathology’s “LC Tao Educator of the Year Award” in 2022 and the ASC’s “Papanicolaou Award” in 2023.
Ashish Chandra, MD FRCPath DipRCPath (Cytol) MIAC (United Kingdom)
Dr. Chandra Is The Lead Consultant For Cytopathology And Uropathology At Guy’s & St Thomas’ NHSFT, London, UK. He Is Currently A Vice-President Of The IAC, Chairman, British Association Of Urological Pathology And Deputy Editor, Cytopathology. His Most Recent Contributions To The Field Of Cytopathology Include The International System For Reporting Serous Fluid Cytopathology And The WHO/IARC Lung Cytopathology Terminology.
Dr. Esperanza Teuzaba Torres, MIAC (Colombia)
Dr. Esperanza Teuzaba Torres is the scientific director of Patolab laboratory, Clinica de la Mujer, Bogota, where practices and training for cytology students take place. Also currently working in the Cervical Cancer Agreement Group, developing guidelines, outlines, and efforts to reduce the incidence and mortality of cervical cancer in Colombia. She also collaborates, as a member of SLAC, with the development and improvement of Cytology in Latin America, with continuing education.
Massimo Bongiovanni, MD, FIAC (Switzerland)
Dr. Bongiovanni is head of Cytopathology at SYNLAB Pathology in Lausanne, Switzerland. He is member of the Pathology Expert Group, at SYNLAB International, Member (MIAC) and then Fellow (FIAC) of the International Academy of Cytology since 2016. He is the author of more than 200 scientific articles and 15 book chapters. He was Vice President of the Swiss Cytology Society (2015-2021) and a member of the Endocrine Tumor Group of the European Organisation for Research and Treatment of Cancer (EORTC). He is associate editor of the journal Acta Cytologica and participates in the editorial board of the journal Diagnostic Cytopathology. He is currently co-chair of the scientific committee of the European Federation of Cytology Societies (EFCS).